Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Sharon Bio-Medicine Ltd

+ Add to Watchlist

SBML:IN

17.25 INR 0.55 3.09%

As of 00:00:17 ET on 05/26/2015.

Snapshot for Sharon Bio-Medicine Ltd (SBML)

Open: 17.75 Day's Range: 17.10 - 17.80 Volume: 23,400
Previous Close: 17.80 52wk Range: 15.40 - 90.35 1-Yr Rtn: -61.30%

Stock Chart for SBML

No chart data available.
  • SBML:IN 17.25
  • 1D
  • 1M
  • 1Y
17.80
Interactive SBML Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SBML

Current P/E Ratio (ttm) 2.6722
Estimated P/E(06/2015) -
Relative P/E vs. SENSEX 0.1217
Earnings Per Share (INR) (ttm) 6.6613
Est. EPS (INR) (06/2015) -
Est. PEG Ratio -
Market Cap (M INR) 1,879.13
Shares Outstanding (M) 105.57
30 Day Average Volume 944,757
Price/Book (mrq) 0.6701
Price/Sale (ttm) 0.1375
Dividend Indicated Gross Yield 2.02%
Cash Dividend (INR) 0.3600
Dividend Ex-Date 12/11/2014
5 Year Dividend Growth 24.57%
Next Earnings Announcement 08/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SBML

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for SBML

Sharon Bio - Medicine Ltd. manufactures chemical intermediates, bulk actives and pharmaceutical formulations. The Company's intermediate product line includes cis bromo benzoate, benzyl amine, di benzyl amine, benzyl amine hydro bromide and benzyl amine hydrochloride. Sharon Bio also focuses on actives products which include sildenafil citrate, letrozole and moxiflacin HCL.

Savita Satish GowdaChairman/Managing Director/CEOLalit MisraExecutive Director
Vijay KirpalaniExecutive DirectorViral Dilip VoraSecretary/Compliance Officer
More Company Profile & Key Executives for SBML

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil